more than 50% MSMEs in pharma to be shutdown early next year.. https://youtu.be/xAs3gMk0e8Y Anshuman Tiwari says The risk of closure has increased for nearly 60% of pharma MSMEs. these companies have not yet adopted Good Manufacturing Practice (GMP) rules, There are approximately 8500 pharma MSMEs that have not yet implemented these rules.
the working methods of these pharmaceutical companies, including adulteration and the mixing of toxic substances in medicines, have damaged the reputation of the Indian pharmaceutical industry worldwide. new GMPs will come into effect from January 1st. There are approximately 10,000 to 12,000 pharmaceutical units in India, of which 8,000 to 9,000 units will close down. This is because the 60% of small and medium-sized companies do not have enough investment or technology to implement the new Good Manufacturing Practice plan.